Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT+PSK vs UFT+LV in Stage IIB/III Colorectal Cancer
NCT00385970Phase 3Unknown
- Sponsor
- Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- Start
- Mar 2006
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes, Microbiome-Derived Products
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of polysaccharide k in colorectal cancer (CRC) (2 arms), sponsored by Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group. Primary endpoint: 3-Year Recurrence-Free Survival Rate. Status: unknown.
02
Drugs
polysaccharide k
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00385970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385970.